Firibastat, the first-in-class brain aminopeptidase a inhibitor, in the management of hypertension: a review of clinical trials

by Sara Abdulrahman Alomar, Sarah Ali Alghabban, Hadeel Abdulaziz Alharbi, Mehad Fahad Almoqati, Yazid Alduraibi, Ahmed Abu-Zaid
Published 2021-01-01